A recent study of twelve-month treatment with GLP-1RA, SGLT-2i, and their combination showed greater improvement in vascular markers and effective cardiac cycles than insulin treatment in type 2 diabetes mellitus. This evidence concerns the gene INS and type 2 diabetes mellitus.